[New inotropic drugs].
Presbitero
P
P
Chiotti
D
D
D000318:Adrenergic beta-Agonists / Q000494:pharmacology / Q000627:therapeutic use; D000676:Amrinone / Q000494:pharmacology / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000494:pharmacology / Q000627:therapeutic use; D003846:Deoxyepinephrine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D017335:Enoximone; D004983:Ethanolamines / Q000494:pharmacology / Q000627:therapeutic use; D006321:Heart / Q000187:drug effects; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology / Q000627:therapeutic use; D020105:Milrinone; D009200:Myocardial Contraction / Q000187:drug effects; D011412:Propanolamines / Q000494:pharmacology / Q000627:therapeutic use; D011724:Pyridazines / Q000494:pharmacology / Q000627:therapeutic use; D011728:Pyridones / Q000494:pharmacology / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use; D017307:Xamoterol
D000318:Adrenergic beta-Agonists; D002316:Cardiotonic Agents; D004983:Ethanolamines; D007093:Imidazoles; D011412:Propanolamines; D011724:Pyridazines; D011728:Pyridones; D014665:Vasodilator Agents; C039686:piroximone; C041648:pimobendan; D017307:Xamoterol; C023487:ibopamine; D017335:Enoximone; C029758:sulmazole; D020105:Milrinone; D000676:Amrinone; C009118:pirbuterol; D003846:Deoxyepinephrine
I nuovi farmaci inotropi.